<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>regulatory compliance &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/regulatory-compliance/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 09 Oct 2025 15:21:28 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>regulatory compliance &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>ISSCR Unveils Roadmap for Advancing Pluripotent Stem Cell-Derived Therapies</title>
		<link>https://bioengineer.org/isscr-unveils-roadmap-for-advancing-pluripotent-stem-cell-derived-therapies/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 09 Oct 2025 15:21:23 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cellular therapy manufacturing]]></category>
		<category><![CDATA[ISSCR best practices]]></category>
		<category><![CDATA[pluripotent stem cell therapies]]></category>
		<category><![CDATA[regulatory compliance]]></category>
		<category><![CDATA[translational research guidelines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/isscr-unveils-roadmap-for-advancing-pluripotent-stem-cell-derived-therapies/</guid>

					<description><![CDATA[The International Society for Stem Cell Research (ISSCR) has unveiled an innovative and comprehensive resource entitled Best Practices for the Development of Pluripotent Stem Cell-Derived Cellular Therapies, marking a pivotal advancement in the domain of regenerative medicine. This dynamic, interactive guide is meticulously designed to expedite the translation of human pluripotent stem cell (PSC)-derived therapies [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">278190</post-id>	</item>
		<item>
		<title>Creating Reference Standards for Polymer Additive Analysis</title>
		<link>https://bioengineer.org/creating-reference-standards-for-polymer-additive-analysis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 31 Jul 2025 01:52:45 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[environmental toxicology]]></category>
		<category><![CDATA[medical device safety]]></category>
		<category><![CDATA[non-targeted chemical profiling]]></category>
		<category><![CDATA[polymer additive analysis]]></category>
		<category><![CDATA[regulatory compliance]]></category>
		<guid isPermaLink="false">https://bioengineer.org/creating-reference-standards-for-polymer-additive-analysis/</guid>

					<description><![CDATA[In a groundbreaking advance for the fields of materials science and medical safety, researchers have developed a comprehensive set of reference standards aimed at transforming the non-targeted analysis of polymer additives extracted from medical devices. This innovative framework addresses long-standing challenges in identifying and quantifying the myriad chemical additives embedded within polymeric materials, which have [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">251992</post-id>	</item>
	</channel>
</rss>
